The Key We Are Overlooking in Peripheral Vascular Disease

To change the prognosis of peripheral vascular disease patients, a referral for supervised exercise is paramount. This should be a cultural change, not only an individual recommendation.

ejercicio y enfermedad vascular periférica

A physically active lifestyle reduces the risk of cardiovascular events and functional impairment in patients with peripheral vascular disease.

The novelty of this work (forthcoming in Eur J Vasc Endovasc Surg) is that it compares physical activity patterns from peripheral vascular disease patients in two countries: one presenting an epidemic of sedentary and overweight individuals (United Stated) and another that actively promotes physical activity as a public health policy (the Netherlands).

Patients self-reported their physical activity following a binary classification (sedentarism or physical activity), with follow-up at 3, 6, and 12 months.

Participants were registered in the Patient-centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) registry, which included patients with new or worsening intermittent claudication.

This study included a total of 1098 patients: 743 recruited in the US (67.7%) and 355 in the Netherlands (32.3%).


Read also: What Is the Healthiest Diet?


American patients were older (mean age: 68.6 years vs. 65.3 years; p < 0.001) and heavier (41.3% vs. 20.5%; p < 0.001), but fewer were smokers (30.1% vs. 52.8%; p < 0.001) and more were female (41.3% vs. 31.4%; p = 0.002).

The main difference between countries was the patients’ supervised exercise baseline (1.6% in the US vs. 63.9% in the Netherlands; p < 0.001). Not only were Americans more sedentary at baseline, but also only a small percentage of them were formally instructed to exercise in a supervised manner.

Conclusion

To change the prognosis of symptomatic peripheral vascular disease patients, a referral for supervised exercise is paramount. Advising them to walk moreis not enough: a cultural change must take place.

Original Title: Physical Activity in Patients with Symptomatic Peripheral Artery Disease: Insights from the PORTRAIT Registry.

Reference: Poghni A. Peri-Okonny et al. Eur J Vasc Endovasc Surg. 2020 Jul 21;S1078-5884(20)30528-1. https://doi.org/10.1016/j.ejvs.2020.06.010.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...